Document is current

Any future updates will be listed below

De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine

Crossref DOI link: https://doi.org/10.1186/s12941-016-0138-0

Published Online: 2016-04-14

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark